SCHEMBL580213

SCHEMBL580213

CC(F)(OC(C)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15299974 0.97 LMNA (0.38) LMNA
SCHEMBL22471718 0.97 LMNA (0.38) LMNA
SCHEMBL890401 0.90
SCHEMBL7679836 0.74 ALDH1A1 (0.33)
SCHEMBL13024756 0.71 LMNA (0.33) LMNA
SCHEMBL9540596 0.70 LMNA (0.41) LMNA
Perflubutane SCHEMBL5188622 0.70 LMNA (0.41) LMNA
SCHEMBL8676322 0.69
SCHEMBL11501540 0.69 TSHR (0.33)
SCHEMBL12603950 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118165587-A Fusible polytetrafluoroethylene coating, preparation method thereof and coated workpiece 福建海德福新材料有限公司 2024-06-11 CN claimed
US-10199677-B2 Electrolytes for lithium ion batteries StoreDot Ltd. (IL) 2019-02-05 US claimed
US-20180008523-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD DEVICEFARM INC (US) 2018-01-11 US claimed
US-20180000937-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD DEVICEFARM INC (US) 2018-01-04 US claimed
US-20170361078-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-21 US claimed
US-20170354616-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-14 US claimed
US-20170354815-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-14 US claimed
US-9364569-B2 Ultrasound contrast agents and process for the preparation thereof BRACCO SUISSE S.A. (CH) 2016-06-14 US claimed
US-20060051297-A1 Ultrasound contrast agents and process for the preparation thereof BRACCO INTERNATIONAL B.V 2006-03-09 US claimed
EP-1590006-A2 ULTRASOUND CONTRAST AGENTS AND PROCESS FOR THE PREPARATION THEREOF BRACCO INTERNATIONAL B.V. (NL) 2005-11-02 EP claimed
WO-2004069284-A2 ULTRASOUND CONTRAST AGENTS AND PROCESS FOR THE PREPARATION THEREOF BRACCO INTERNATIONAL B.V. (NL) 2004-08-19 WO claimed
EP-1032357-A1 USE OF FLUORINATED SOLVENTS FOR THE FORMULATION OF HAIR LOTIONS Extractive S.A. (FR) 2000-09-06 EP claimed
WO-1999026594-A1 USE OF FLUORINATED SOLVENTS FOR THE FORMULATION OF HAIR LOTIONS EXTRACTIVE (SOCIETE ANONYME) (FR) 1999-06-03 WO claimed
US-20240222614-A1 LITHIUM SECONDARY BATTERY TERAWATT TECHNOLOGY K.K. (JP) 2024-07-04 US disclosed
CN-117957266-A Fluoropolyether group-containing polymer, surface treatment agent and article 信越化学工业株式会社 2024-04-30 CN disclosed
CN-117840009-A Method for forming coating film of photocurable fluoropolyether elastomer composition 信越化学工业株式会社 2024-04-09 CN disclosed
US-20020071959-A1 Perfluoropolyether-modified aminosilane, surface treating agent and coated article SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-06-13 US disclosed
EP-1032357-A1 USE OF FLUORINATED SOLVENTS FOR THE FORMULATION OF HAIR LOTIONS Extractive S.A. (FR) 2000-09-06 EP disclosed
WO-1999026594-A1 USE OF FLUORINATED SOLVENTS FOR THE FORMULATION OF HAIR LOTIONS EXTRACTIVE (SOCIETE ANONYME) (FR) 1999-06-03 WO disclosed
US-5733416-A WATER DISPLACEMENT WITH LIQUID AND SURFACTANT, ENTRAINMENT AND CIRCULATION AND DISTILLATION ENTROPIC SYSTEMS, INC. (US) 1998-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020071959-A1 Perfluoropolyether-modified aminosilane, surface treating agent and coated article PHOSPHO1, PFAS, FFAR1 LMNA 1538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.